RxDoctor Payments DataLook up a doctor →

Alida Reinoso

Miami, FLNPI 1831358233

Payments from drug & device makers

$3,371,220in general payments, 2019–2025

Across 721 payments — averaging $4675.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.2M
  • AbbVie$1.1M
  • Supernus Pharmaceuticals, Inc.$56K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)558$2,209,350
AbbVie(2 entities)155$1,106,255
Supernus Pharmaceuticals, Inc.8$55,616

Where these figures come from

Is this you, or does something look wrong? →